Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $491.12 | 16 | 100.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| ABBVIE INC. | $317.35 | 11 | $0 (2024) |
| Otsuka America Pharmaceutical, Inc. | $115.20 | 1 | $0 (2023) |
| Takeda Pharmaceuticals U.S.A., Inc. | $28.16 | 2 | $0 (2021) |
| Alkermes, Inc. | $17.86 | 1 | $0 (2022) |
| Lundbeck LLC | $12.55 | 1 | $0 (2022) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $40.81 | 2 | ABBVIE INC. ($40.81) |
| 2023 | $245.29 | 6 | ABBVIE INC. ($130.09) |
| 2022 | $141.43 | 4 | ABBVIE INC. ($111.02) |
| 2021 | $63.59 | 4 | AbbVie Inc. ($35.43) |
All Payment Transactions
16 individual payment records from CMS Open Payments
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 03/08/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $15.57 | General |
| Category: NEUROSCIENCE | ||||||
| 01/24/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $25.24 | General |
| Category: NEUROSCIENCE | ||||||
| 12/01/2023 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $22.49 | General |
| Category: NEUROSCIENCE | ||||||
| 12/01/2023 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $10.92 | General |
| Category: NEUROSCIENCE | ||||||
| 09/15/2023 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $9.09 | General |
| Category: NEUROSCIENCE | ||||||
| 05/31/2023 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $12.12 | General |
| Category: NEUROSCIENCE | ||||||
| 05/23/2023 | Otsuka America Pharmaceutical, Inc. | REXULTI (Drug) | Food and Beverage | In-kind items and services | $115.20 | General |
| Category: PSYCHIATRY | ||||||
| 05/11/2023 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $75.47 | General |
| Category: NEUROSCIENCE | ||||||
| 04/13/2022 | Lundbeck LLC | REXULTI (Drug) | Food and Beverage | Cash or cash equivalent | $12.55 | General |
| Category: PSYCHIATRY | ||||||
| 04/06/2022 | Alkermes, Inc. | LYBALVI (Drug), LYBALVI, LYBALVI | Food and Beverage | In-kind items and services | $17.86 | General |
| Category: CNS | ||||||
| 03/24/2022 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $98.87 | General |
| Category: NEUROSCIENCE | ||||||
| 02/23/2022 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $12.15 | General |
| Category: NEUROSCIENCE | ||||||
| 10/13/2021 | AbbVie Inc. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $13.64 | General |
| Category: NEUROSCIENCE | ||||||
| 09/15/2021 | AbbVie Inc. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $21.79 | General |
| Category: NEUROSCIENCE | ||||||
| 08/30/2021 | Takeda Pharmaceuticals U.S.A., Inc. | TRINTELLIX (Drug) | Food and Beverage | In-kind items and services | $15.36 | General |
| Category: NEUROSCIENCE | ||||||
| 07/07/2021 | Takeda Pharmaceuticals U.S.A., Inc. | TRINTELLIX (Drug) | Food and Beverage | In-kind items and services | $12.80 | General |
| Category: NEUROSCIENCE | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 4 | 99 | 425 | $45,020 | $26,229 |
| 2022 | 3 | 101 | 453 | $45,685 | $26,146 |
| 2021 | 5 | 146 | 578 | $59,585 | $35,155 |
| 2020 | 4 | 150 | 751 | $75,275 | $40,414 |
All Medicare Procedures & Services
16 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 34 | 207 | $17,595 | $12,797 | 72.7% |
| 90836 | Psychotherapy with evaluation and management visit, 45 minutes | Office | 2023 | 32 | 160 | $20,000 | $9,638 | 48.2% |
| 90838 | Psychotherapy with evaluation and management visit, 1 hour | Office | 2023 | 15 | 32 | $4,800 | $2,567 | 53.5% |
| 90833 | Psychotherapy with evaluation and management visit, 30 minutes | Office | 2023 | 18 | 26 | $2,625 | $1,227 | 46.7% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 38 | 231 | $19,635 | $13,696 | 69.8% |
| 90836 | Psychotherapy with evaluation and management visit, 45 minutes | Office | 2022 | 33 | 153 | $19,125 | $9,292 | 48.6% |
| 90833 | Psychotherapy with evaluation and management visit, 30 minutes | Office | 2022 | 30 | 69 | $6,925 | $3,159 | 45.6% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 45 | 262 | $22,270 | $16,701 | 75.0% |
| 90836 | Psychotherapy with evaluation and management visit, 45 minutes | Office | 2021 | 44 | 221 | $27,625 | $13,471 | 48.8% |
| 90833 | Psychotherapy performed with evaluation and management visit, 30 minutes | Office | 2021 | 27 | 48 | $4,800 | $2,362 | 49.2% |
| 90838 | Psychotherapy with evaluation and management visit, 60 minutes | Office | 2021 | 11 | 20 | $3,000 | $1,727 | 57.6% |
| 99212 | Established patient outpatient visit, total time 10-19 minutes | Office | 2021 | 19 | 27 | $1,890 | $894.49 | 47.3% |
| 90836 | Psychotherapy, 45 minutes | Office | 2020 | 41 | 313 | $39,125 | $20,068 | 51.3% |
| 99213 | Established patient office or other outpatient visit, typically 15 minutes | Office | 2020 | 40 | 246 | $20,910 | $13,158 | 62.9% |
| 99212 | Established patient office or other outpatient visit, typically 10 minutes | Office | 2020 | 37 | 132 | $9,240 | $4,184 | 45.3% |
| 90833 | Psychotherapy, 30 minutes | Office | 2020 | 32 | 60 | $6,000 | $3,003 | 50.0% |
About Maria Dubois, NP
Maria Dubois, NP is a Nurse Practitioner healthcare provider based in Woodstock, New York. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 08/31/2006. The National Provider Identifier (NPI) number assigned to this provider is 1386755650.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Maria Dubois, NP has received a total of $491.12 in payments from pharmaceutical and medical device companies, with $40.81 received in 2024. These payments were reported across 16 transactions from 5 companies. The most common payment nature is "Food and Beverage" ($491.12).
As a Medicare-enrolled provider, Dubois has provided services to 496 Medicare beneficiaries, totaling 2,207 services with total Medicare billing of $127,945. Data is available for 4 years (2020–2023), covering 16 distinct procedure/service records.
Practice Information
- Specialty Nurse Practitioner
- Other Specialties Family, Psychiatric/Mental Health
- Location Woodstock, NY
- Active Since 08/31/2006
- Last Updated 11/20/2019
- Taxonomy Code 363L00000X
- Entity Type Individual
- Practice Solo Practitioner
- NPI Number 1386755650
Products in Payments
- VRAYLAR (Drug) $317.35
- REXULTI (Drug) $127.75
- TRINTELLIX (Drug) $28.16
- LYBALVI (Drug) $17.86
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Nurse Practitioner Doctors in Woodstock
Mrs. Mary Bedingfield, Msn,Np-C, MSN,NP-C
Nurse Practitioner — Payments: $12,863
Mrs. Melissa Dubois, Np-C, NP-C
Nurse Practitioner — Payments: $6,152
Mrs. Kelly Nix, Fnp, Bc, FNP, BC
Nurse Practitioner — Payments: $2,417
Ms. Sharnee Straub, Cnp, CNP
Nurse Practitioner — Payments: $1,759
Angela Astleford, Cnp, CNP
Nurse Practitioner — Payments: $1,429
Mrs. Vicky Bryan, Fnp-C, FNP-C
Nurse Practitioner — Payments: $1,205